INSUBCONTINENT EXCLUSIVE:
Both these companies are expected to report double-digit rise in bottomline figures for the quarter.
Centrum Broking expects net profit of
good sales growth and margin improvement
to grow by 5 per cent YoY and grow by 2 per cent QoQ to Rs 3,060 crore due to strong growth in India
in a report.
CIPLAOther drug major, Cipla is likely to report profit in the fourth quarter against loss of Rs 62 crore last
year.
ICICIdirect.com sees revenues growing by around 8 per cent YoY mainly due to 12 per cent growth in domestic formulations
The brokerage house projects a profit of Rs 298 crore in March quarter.
Axis Capital is expecting profit of Rs 340 crore from Cipla for the
It further expects that ebitda, sales and ebitda margin may increase by 23 per cent, 7 per cent and 215 basis points, respectively, in
hand, South Africa sales are expected to grow 20 per cent YoY due to favorable currency movement and improvement in constant currency
growth, according to ICICIdirect.com.
